Abstract
A novel cyanine-rhenium(i) tricarbonyl complex is developed as a potent sonosensitizer and sono-activatable CO-releasing agent for synergistic sonodynamic therapy and CO gas therapy of cancer. The complex induced ferroptosis as the mode of cell death.
Cite
CITATION STYLE
APA
Zhu, J., Ouyang, A., He, J., Xie, J., Banerjee, S., Zhang, Q., & Zhang, P. (2022). An ultrasound activated cyanine-rhenium(i) complex for sonodynamic and gas synergistic therapy. Chemical Communications, 58(20), 3314–3317. https://doi.org/10.1039/d1cc06769a
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free